EFFICACY OF THE NICOTINE INHALER AS AN ADJUNCT TO SMOKING CESSATION

A randomized double-blind placebo-controlled clinical trial was conduc ted to assess the efficacy of a nicotine inhaler as an adjunct to smok ing cessation. One hundred, eleven subjects were randomized to each co ndition. Subjects received brief individual support regarding proper i nhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences In abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.